GleamWall
中文EN

TRFA TRAFALGAR INTERNATIONAL, INC.

Pharmaceutical Preparations · OTC · SEC CIK 1695473 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY215.8%
TTM EPS YoY267.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA7,690.5%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets92,409.0%
Debt / equity—
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.15x
Accruals ratio8,817.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue————————
Operating income-$90,335-$11,555-$33,376-$53,806-$37,412-$48,251-$43,536-$37,625
Interest expense————-$1,313$885——
Pretax income-$90,335$611,378-$33,376$337,757-$36,099-$390,853-$103,511-$43,348
Net income-$90,335$611,378-$33,376$337,757-$36,099-$390,853-$242,417-$43,348
EPS (basic)-0.450.610.00—-0.20-0.430.00—
EPS (diluted)-0.450.610.00—-0.20-0.430.00—
Weighted avg. shares (diluted)199,153994,379944,935—180,303919,141910.37M—
Balance sheet
Cash & equivalents$111$111$1,439$815$21,355$26,712$46,213$57,368
Current assets$111$111$1,439$815$21,355$26,712$46,213$57,368
Total assets$111$111$1,439$815$21,355$26,712$46,213$57,785
Current liabilities—$12,239$776,464$742,464$1.13M$1.10M$1.01M$898,058
Total liabilities$102,574$12,239$776,464$742,464$1.13M$1.10M$1.01M$898,058
Shareholders' equity-$102,463-$12,128-$775,025-$741,649-$1.11M-$1.07M-$962,890-$840,273
Shares outstanding199,153994,379944,935189,250900,2561.35B974.89M536,622
Cash flow statement
Operating cash flow-$85,624-$6,828-$4,376-$24,140-$5,357-$19,501-$11,155-$4,914
Financing cash flow$85,624$5,500$5,000—————
Stock-based compensation———$0$0$0$1,800—

Free plan shows the latest 8 periods; Pro shows all 41 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.